|Articles|January 21, 2016
Optum, Parexel Will Offer EHR-Fueled and Hybrid Studies
The alliance will offer hybrid studies that combine existing data from electronic health records (EHRs) and medical claims (from Optum) with global, site-based clinical research (Parexel).
Advertisement
Optum, an information and technology-enabled health services business and part of UnitedHealth, and Parexel International have formed a strategic alliance. The alliance will offer hybrid studies that combine existing data from electronic health records (EHRs) and medical claims (from Optum) with global, site-based clinical research expertise (Parexel), with the goal of accelerating the post-approval collection of clinical evidence.
Read the
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
2
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
5